推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

ACTA PHARMACOLOGICA SINICA

2023年12月最新中科院分区表数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 ACTA PHARMACOL 最新评论:您好,请问多久分配编辑啊 (2024-02-26)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中科院分区:   是否OA期刊:   结果排序:

同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


ACTA PHARMACOLOGICA SINICA期刊基本信息Hello,您是该期刊的第145982位访客

基本信息 登录收藏
期刊名字ACTA PHARMACOLOGICA SINICAACTA PHARMACOLOGICA SINICA

ACTA PHARMACOL SIN
(此期刊被最新的JCR期刊SCIE收录)



LetPub评分
8.6
60人评分
我要评分

声誉
9.7

影响力
7.6

速度
9.5

期刊ISSN1671-4083
微信扫码收藏此期刊
E-ISSN1745-7254
2022-2023最新影响因子
(数据来源于搜索引擎)
8.2 点击查看影响因子趋势图
实时影响因子 截止2024年3月26日:7.009
2022-2023自引率2.40%点击查看自引率趋势图
五年影响因子8.2
h-index 78
CiteScore
CiteScoreSJRSNIPCiteScore排名
12.201.6771.510
学科分区排名百分位
大类:Medicine
小类:Pharmacology (medical)
Q19 / 260
大类:Medicine
小类:Pharmacology
Q121 / 301

期刊简介
APS (Acta Pharmacologica Sinica) encourages submissions from all areas of pharmacology and the life sciences. Topics of particular interest include, but are not limited to, anticancer pharmacology, cardiovascular and pulmonary pharmacology, clinical pharmacology, drug discovery, gastrointestinal and hepatic pharmacology, genitourinary, renal and endocrine pharmacology, immunopharmacology and inflammation, molecular and cellular pharmacology, neuropharmacology, pharmaceutics and pharmacokinetics.
期刊官方网站https://www.nature.com/aps
期刊投稿网址https://mc.manuscriptcentral.com/aphs

优惠提示:
Acta Pharmacologica Sinica期刊推荐使用LetPub进行必要的文章语言润色服务,下单时您使用该期刊的专属优惠代码“APS10%”即可享受10%的折扣。
作者指南网址https://www.nature.com/aps/authors-and-referees
期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足ACTA PHARMACOLOGICA SINICA的语言要求,还能让ACTA PHARMACOLOGICA SINICA编辑和审稿人得到更好的审稿体验,让稿件最大限度地被ACTA PHARMACOLOGICA SINICA编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问No
通讯方式294 Tai-Yuan Road, Shanghai 200031, China
出版商Nature Publishing Group
涉及的研究方向医学-化学综合
出版国家或地区PEOPLES R CHINA
出版语言English
出版周期Monthly
出版年份1980
年文章数 187点击查看年文章数趋势图
Gold OA文章占比6.37%
研究类文章占比:
文章 ÷(文章 + 综述)
79.68%
WOS期刊SCI分区
2022-2023年最新版
WOS分区等级:1区

按学科分区JIF分区JIF排名JIF百分位
学科:CHEMISTRY, MULTIDISCIPLINARY
类别:SCIE
Q136/178
学科:PHARMACOLOGY & PHARMACY
类别:SCIE
Q117/277
中科院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中科院SCI期刊分区
2023年12月最新升级版
点击查看中科院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 3区1区2区
PHARMACOLOGY & PHARMACY
药学
3区3区1区
CHEMISTRY, MULTIDISCIPLINARY
化学:综合
2区3区2区
中科院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 2区1区2区
CHEMISTRY, MULTIDISCIPLINARY
化学:综合
4区1区1区
PHARMACOLOGY & PHARMACY
药学
1区1区1区
中科院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 1区1区4区
PHARMACOLOGY & PHARMACY
药学
3区3区1区
CHEMISTRY, MULTIDISCIPLINARY
化学综合
2区4区2区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1671-4083%5BISSN%5D
平均审稿速度网友分享经验:
平均2月
平均录用比例网友分享经验:
约63.75%
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在ACTA PHARMACOLOGICA SINICA顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
编辑信息 Editor-in-Chief
Jian Ding (Shanghai)

Associate Editors
Guan-hua Du (Beijing)
Dayue Duan (Reno)
Meiyu Geng (Shanghai)
Ming-wei Wang (Shanghai)
Jie Wu (Phoenix)
Eric Huaqiang Xu (Grand Rapids)
Bao-feng Yang (Harbin)
Qiang Yu (Shanghai)
Jian-ping Zuo (Shanghai)
期刊常用信息链接
同领域相关期刊 ACTA PHARMACOLOGICA SINICA期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 ACTA PHARMACOLOGICA SINICA中科院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
ACTA PHARMACOLOGICA SINICA上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中科院SCI期刊分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发表论文
  • 中科院SCI期刊分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    CHEMICAL REVIEWS609102.70
    CHEMICAL SOCIETY REVIEWS43281.30
    Nature Chemistry18731.70
    ACCOUNTS OF CHEMICAL RESEARCH35434.70
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION48226.30
    Journal of the American Chemical Society54225.70
    JOURNAL OF CONTROLLED RELEASE23717.10
    GREEN CHEMISTRY18616.40
    CHINESE CHEMICAL LETTERS4111.80
    Topics in Current Chemistry8511.70
    中科院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE608527
    BIOMATERIALS518780
    BIOMEDICINE & PHARMACOTHERAPY471781
    Journal of Materials Chemistry B463878
    Frontiers in Pharmacology456205
    Frontiers in Immunology428035
    JOURNAL OF ETHNOPHARMACOLOGY410969
    COLLOIDS AND SURFACES B-BIOINTERFACES407344
    Frontiers in Oncology388808
    Acta Biomaterialia380177
  •  

    ACTA PHARMACOLOGICA SINICA ACTA PHARMACOLOGICA SINICA
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Caffeic acid phenethyl ester suppresses intestinal FXR signaling and ameliorates nonalcoholic fatty liver disease by inhibiting bacterial bile salt hydrolase activity

    Author: Zhong, Xian-Chun; Liu, Ya-Meng; Gao, Xiao-Xia; Krausz, Kristopher W.; Niu, Bing; Gonzalez, Frank J.; Xie, Cen
    Journal: ACTA PHARMACOLOGICA SINICA. 2023; Vol. 44, Issue 1, pp. 145-156. DOI: 10.1038/s41401-022-00921-7
        PubMed      DOI
    2.Hepatocyte-derived MANF mitigates ethanol-induced liver steatosis in mice via enhancing ASS1 activity and activating AMPK pathway

    Author: Xu, Han-Yang; Jiao, Yan-Hong; Li, Shi-Yu; Zhu, Xu; Wang, Sheng; Zhang, Yu-Yang; Wei, Yi-Jun; Shen, Yu-Jun; Wang, Wei; Shen, Yu-Xian; Shao, Jun-Tang
    Journal: ACTA PHARMACOLOGICA SINICA. 2023; Vol. 44, Issue 1, pp. 157-168. DOI: 10.1038/s41401-022-00920-8
        PubMed      DOI
    3.Urolithin A ameliorates obesity-induced metabolic cardiomyopathy in mice via mitophagy activation

    Author: Huang, Jian-rong; Zhang, Ming-hua; Chen, Ying-jie; Sun, Yu-ling; Gao, Zhi-min; Li, Zhuo-jia; Zhang, Gui-ping; Qin, Yuan; Dai, Xiao-yan; Yu, Xi-yong; Wu, Xiao-qian
    Journal: ACTA PHARMACOLOGICA SINICA. 2023; Vol. 44, Issue 2, pp. 321-331. DOI: 10.1038/s41401-022-00919-1
        PubMed      DOI
    4.Calcipotriol abrogates cancer-associated fibroblast-derived IL-8-mediated oxaliplatin resistance in gastric cancer cells via blocking PI3K/Akt signaling

    Author: Zhao, Zhen-Xiong; Zhang, Yan-Qiu; Sun, Hui; Chen, Zi-Qi; Chang, Jin-Jia; Wang, Xin; Wang, Xu; Tan, Cong; Ni, Shu-Juan; Weng, Wei-Wei; Zhang, Meng; Wang, Lei; Huang, Dan; Feng, Yun; Sheng, Wei-Qi; Xu, Mi-Die
    Journal: ACTA PHARMACOLOGICA SINICA. 2023; Vol. 44, Issue 1, pp. 178-188. DOI: 10.1038/s41401-022-00927-1
        PubMed      DOI
    5.Pharmacokinetics, mass balance, and metabolism of [C-14]TPN171, a novel PDE5 inhibitor, in humans for the treatment of pulmonary arterial hypertension

    Author: He, Yi-fei; Liu, Yin; Yu, Jing-hua; Cheng, Huan; Odilov, Abdullajon; Yang, Fei-pu; Tian, Guang-hui; Yao, Xiu-mei; Duan, Hua-qing; Yu, Cheng-yin; Yu, Chen; Liu, Yan-mei; Liu, Gang-yi; Shen, Jing-shan; Wang, Zhen; Diao, Xing-xing
    Journal: ACTA PHARMACOLOGICA SINICA. 2023; Vol. 44, Issue 1, pp. 221-233. DOI: 10.1038/s41401-022-00922-6
        PubMed      DOI
    6.Dectin-1 plays a deleterious role in high fat diet-induced NAFLD of mice through enhancing macrophage activation

    Author: Wang, Min-xiu; Luo, Wu; Ye, Lin; Jin, Lei-ming; Yang, Bin; Zhang, Qian-hui; Qian, Jian-chang; Wang, Yi; Zhang, Yi; Liang, Guang
    Journal: ACTA PHARMACOLOGICA SINICA. 2023; Vol. 44, Issue 1, pp. 120-132. DOI: 10.1038/s41401-022-00926-2
        PubMed      DOI
    7.Dual-responsive nanoparticles loading bevacizumab and gefitinib for molecular targeted therapy against non-small cell lung cancer

    Author: Zhao, Zi-tong; Wang, Jue; Fang, Lei; Qian, Xin-di; Cai, Ying; Cao, Hai-qiang; Wang, Guan-ru; He, Mei-lin; Jiang, Yan-yan; Wang, Dang-ge; Li, Ya-ping
    Journal: ACTA PHARMACOLOGICA SINICA. 2023; Vol. 44, Issue 1, pp. 244-254. DOI: 10.1038/s41401-022-00930-6
        PubMed      DOI
    8.Silybin regulates P450s activity by attenuating endoplasmic reticulum stress in mouse nonalcoholic fatty liver disease

    Author: Wu, Jing; Lou, Yun-ge; Yang, Xu-le; Wang, Rui; Zhang, Ran; Aa, Ji-ye; Wang, Guang-ji; Xie, Yuan
    Journal: ACTA PHARMACOLOGICA SINICA. 2023; Vol. 44, Issue 1, pp. 133-144. DOI: 10.1038/s41401-022-00924-4
        PubMed      DOI
    9.Costunolide alleviates atherosclerosis in high-fat diet-fed ApoE(-/-) mice through covalently binding to IKK beta and inhibiting NF-kappa B-mediated inflammation

    Author: Huang, Zhu-Qi; Luo, Wu; Li, Wei-Xin; Chen, Pan; Wang, Zhe; Chen, Rui-Jie; Wang, Yi; Huang, Wei-Jian; Liang, Guang
    Journal: ACTA PHARMACOLOGICA SINICA. 2023; Vol. 44, Issue 1, pp. 58-70. DOI: 10.1038/s41401-022-00928-0
        PubMed      DOI
    10.Hederacoside C ameliorates colitis via restoring impaired intestinal barrier through moderating S100A9/MAPK and neutrophil recruitment inactivation

    Author: Zha, Zheng-xia; Lin, Yu; Wang, Ke-xin; Zhang, Yan-lin; Li, Dan; Xu, Guo-qiang; Xu, Qiong-ming; Liu, Yan-li
    Journal: ACTA PHARMACOLOGICA SINICA. 2023; Vol. 44, Issue 1, pp. 105-119. DOI: 10.1038/s41401-022-00933-3
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE MEDICINE497107.50
    Nature Reviews Disease Primers4860.90
    同分区等级的其他期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    NATURE REVIEWS MOLECULAR CELL BIOLOGY386164.40
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE REVIEWS MICROBIOLOGY25060.20


以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

    同领域作者分享投稿经验:共174条 (包含回复)

我来分享

    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海分公司    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960

    增值电信业务经营许可证:沪B2-20211595

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室

    United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451